18 results on '"Yurugi, Hajime"'
Search Results
2. Abstract 5987: Differential targets engaged by narazaciclib in comparison to the approved CDK4/6 inhibitors contribute to enhanced inhibition of tumor cell growth
3. Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis
4. Narazaciclib’s kinase inhibitory activity is differentiated from approved CDK4/6 inhibitors in preclinical models.
5. Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
6. ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression
7. Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases
8. A subset of flavaglines inhibits KRAS nanoclustering and activation
9. Targeting prohibitins at the cell surface prevents Th17‐mediated autoimmunity
10. Cover Feature: Mannose-Decorated Multicomponent Supramolecular Polymers Trigger Effective Uptake into Antigen-Presenting Cells (ChemBioChem 9/2018)
11. Mannose-Decorated Multicomponent Supramolecular Polymers Trigger Effective Uptake into Antigen-Presenting Cells
12. Ubiquitin-dependent regulation of Cdc42 by XIAP
13. PRG-1 Regulates Synaptic Plasticity via Intracellular PP2A/β1-Integrin Signaling
14. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo
15. A Role for Prohibitin in Mast Cell Activation: Location Matters
16. Prohibitins function as endogenous ligands for Siglec-9 and negatively regulate TCR signaling upon ligation
17. Expression of prohibitins on the surface of activated T cells
18. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.